Total Payments
$279,223
2024 Payments
$85,101
Companies
39
Transactions
642
Medicare Patients
7,794
Medicare Billing
$464,228
Payment Breakdown by Category
Other$122,611 (43.9%)
Consulting$111,678 (40.0%)
Travel$29,534 (10.6%)
Food & Beverage$15,176 (5.4%)
Education$115.83 (0.0%)
Research$108.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $111,678 | 89 | 40.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54,528 | 33 | 19.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $39,763 | 19 | 14.2% |
| Travel and Lodging | $29,534 | 90 | 10.6% |
| Honoraria | $28,321 | 30 | 10.1% |
| Food and Beverage | $15,176 | 378 | 5.4% |
| Education | $115.83 | 2 | 0.0% |
| Unspecified | $108.50 | 1 | 0.0% |
Payments by Type
General
$279,115
641 transactions
Research
$108.50
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glaukos Corporation | $88,720 | 127 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $55,337 | 85 | $0 (2024) |
| Alcon Vision LLC | $24,587 | 72 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $19,156 | 44 | $0 (2021) |
| Oyster Point Pharma, Inc. | $18,827 | 43 | $0 (2024) |
| Dompe US, Inc. | $16,940 | 26 | $0 (2024) |
| Sight Sciences, Inc. | $13,433 | 27 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $9,905 | 29 | $0 (2024) |
| Thea Pharma Inc. | $8,039 | 17 | $0 (2024) |
| Heru, Inc. | $5,000 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85,101 | 172 | Bausch & Lomb Americas Inc. ($48,541) |
| 2023 | $52,988 | 93 | Glaukos Corporation ($20,448) |
| 2022 | $52,189 | 109 | Oyster Point Pharma, Inc. ($15,625) |
| 2021 | $32,237 | 62 | Glaukos Corporation ($20,518) |
| 2020 | $27,325 | 48 | Glaukos Corporation ($11,338) |
| 2019 | $18,351 | 73 | Aerie Pharmaceuticals, Inc. ($8,797) |
| 2018 | $7,768 | 44 | Glaukos Corporation ($3,831) |
| 2017 | $3,265 | 41 | Glaukos Corporation ($1,727) |
All Payment Transactions
642 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Ophthalmology | ||||||
| 12/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Ophthalmology | ||||||
| 12/18/2024 | Carl Zeiss Meditec USA, Inc. | ATLAS 500 (Device), CIRRUS 6000 with AngioPlex, CIRRUS HD-OCT | Consulting Fee | Cash or cash equivalent | $350.00 | General |
| Category: Optical Topographer | ||||||
| 12/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $1,433.40 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $66.31 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $1,041.15 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $61.41 | General |
| Category: Ophthalmology | ||||||
| 12/05/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Ophthalmology | ||||||
| 12/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Ophthalmology | ||||||
| 12/02/2024 | Glaukos Corporation | Photrexa (Drug) | Food and Beverage | Cash or cash equivalent | $61.62 | General |
| Category: Corneal Health | ||||||
| 11/25/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO, INFUSE | Compensation for serving as faculty or as a speaker for a medical education program | In-kind items and services | $3,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/25/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug), MIEBO, INFUSE | Food and Beverage | In-kind items and services | $269.31 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $103.26 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | Alcon Vision LLC | Rhopressa (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Ophthalmology | ||||||
| 11/20/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Consulting Fee | Cash or cash equivalent | $2,310.00 | General |
| Category: Corneal Health | ||||||
| 11/20/2024 | Glaukos Corporation | — | Consulting Fee | Cash or cash equivalent | $770.00 | General |
| 11/18/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $1,211.28 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $124.58 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: Inflammation/Rare Disease | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension | ABBVIE INC. | $108.50 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,869 | 2,351 | $358,986 | $113,837 |
| 2022 | 17 | 2,131 | 2,584 | $365,068 | $123,386 |
| 2021 | 21 | 2,011 | 2,545 | $354,577 | $122,524 |
| 2020 | 20 | 1,783 | 2,151 | $315,678 | $104,481 |
Total Patients
7,794
Total Services
9,631
Medicare Billing
$464,228
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 273 | 273 | $93,093 | $30,124 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 287 | 412 | $61,800 | $25,302 | 40.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 241 | 324 | $60,588 | $15,040 | 24.8% |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | Office | 2023 | 13 | 100 | $19,800 | $11,204 | 56.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 94 | $20,868 | $8,519 | 40.8% |
| 92133 | Imaging of optic nerve | Office | 2023 | 226 | 281 | $26,133 | $6,964 | 26.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 59 | 68 | $7,140 | $2,699 | 37.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $8,512 | $2,654 | 31.2% |
| 92145 | Measurement of corneal pressure | Office | 2023 | 229 | 290 | $15,370 | $2,361 | 15.4% |
| 92134 | Imaging of retina | Office | 2023 | 73 | 75 | $6,975 | $2,077 | 29.8% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 42 | 83 | $6,270 | $1,828 | 29.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 90 | 92 | $7,452 | $1,789 | 24.0% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 128 | 128 | $7,424 | $967.42 | 13.0% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 29 | 29 | $7,395 | $804.49 | 10.9% |
| 92025 | Ct scan of cornea | Office | 2023 | 27 | 27 | $2,187 | $688.47 | 31.5% |
| 68841 | Insertion of drug delivery implant into tear duct of eye | Office | 2023 | 13 | 14 | $7,174 | $555.60 | 7.7% |
| 83516 | Analysis of substance using immunoassay technique, multiple step method | Office | 2023 | 12 | 23 | $805.00 | $259.90 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 378 | 378 | $118,030 | $41,995 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 284 | 399 | $54,682 | $24,341 | 44.5% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 280 | 343 | $58,807 | $15,859 | 27.0% |
| J1096 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg | Office | 2022 | 15 | 108 | $19,035 | $12,623 | 66.3% |
| 92133 | Imaging of optic nerve | Office | 2022 | 281 | 329 | $28,187 | $7,979 | 28.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 153 | 155 | $11,511 | $3,085 | 26.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $8,161 | $2,950 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 30 | $6,210 | $2,646 | 42.6% |
About Dr. Mitchel Ibach, O.D
Dr. Mitchel Ibach, O.D is a Optometrist healthcare provider based in Sioux Falls, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1184934069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchel Ibach, O.D has received a total of $279,223 in payments from pharmaceutical and medical device companies, with $85,101 received in 2024. These payments were reported across 642 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($111,678).
As a Medicare-enrolled provider, Ibach has provided services to 7,794 Medicare beneficiaries, totaling 9,631 services with total Medicare billing of $464,228. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Sioux Falls, SD
- Active Since 10/13/2010
- Last Updated 04/06/2016
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1184934069
Products in Payments
- MIEBO (Drug) $46,869
- TYRVAYA (Drug) $17,552
- Rhopressa (Drug) $15,128
- KXL system (not refurbished) (Device) $14,248
- Rocklatan (Drug) $13,765
- CE-marked KXLA system (Device) $12,794
- Cequa (Drug) $9,748
- ILINK (Device) $8,400
- OMNI (Device) $8,164
- XIIDRA (Drug) $7,297
- rocklatan (Drug) $6,765
- Heru HMD (Device) $5,000
- rhopressa (Drug) $4,871
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $4,571
- OMNI(R) SURGICAL SYSTEM (US) (Device) $4,479
- VUITY (Drug) $3,322
- IYUZEH (Drug) $3,282
- AcrySof (Device) $2,907
- Oxervate (Drug) $2,293
- iStent inject W (Device) $2,100
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Sioux Falls
Justin Schweitzer, O.d, O.D
Optometrist — Payments: $726,622
Optometrist $726,622
Jason Schmit, O.d, O.D
Optometrist — Payments: $97,145
Optometrist $97,145
Mr. Jeffery Sayler, Od, OD
Optometrist — Payments: $9,552
Optometrist $9,552
Travis Lehr, Od, OD
Optometrist — Payments: $7,237
Optometrist $7,237
Dr. Ryan Haiar, O.d, O.D
Optometrist — Payments: $6,861
Optometrist $6,861
Dr. Matthew Clarke, O.d, O.D
Optometrist — Payments: $4,973
Optometrist $4,973